Synthesis and evaluation of copper radiopharmaceuticals with mixed bis(thiosemicarbazone) ligands

Nuclear Medicine and Biology

Volumn 26, Issue 5, 1999, Pages 551-554

  Ackerman, Lily J ^a   West, Douglas X ^a   Mathias, Carla J ^b   Green, Mark A ^b  

^a ILLINOIS STATE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Copper; PET; Radiopharmaceutical; Thiosemicarbazone

Indexed keywords

BIS(THIOSEMICARBAZONE); COPPER 67; COPPER COMPLEX; LIGAND; METHYLGLYOXAL; RADIOPHARMACEUTICAL AGENT; SERUM ALBUMIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DOG; DRUG DISTRIBUTION; DRUG PROTEIN BINDING; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG UPTAKE; HEART; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT; TISSUE PERFUSION;

EID: 0032813045     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(99)00020-7     Document Type: Article

References (26)

1. Bates R.G., Vega C.A., White D.R. Standards for pH measurements in isotonic saline media of ionic strength I = 0.16. Anal. Chem. 50:1978;1295-1300.
2. Beanlands R.S.B., Muzik O., Hutchins G.D., Woulfe E.R., Schwaiger M. Heterogeneity of regional nitrogen-13-labeled ammonia tracer distribution in the normal human heart Comparison with rubidium-82 and copper-62-labeled PTSM . J. Nucl. Cardiol. 1:1994;225-235.
3. Beanlands R.S., Muzik O., Mintun M.A., Mangner T., Lee K., Petry N., Hutchins G.D., Schwaiger M. The kinetics of copper-62-PTSM in the normal human heart. J. Nucl. Med. 33:1992;684-690.
4. 3-diethylthiosemicarbazone}. Polyhderon. 17:1998;2751-2757.
5. 4-methylthiosemicarbazone) (Cu-PTSM) by brain and tumor A novel radiopharmaceutical for positron emission tomography imaging . Ann. Nucl. Med. 9:1995;1-5.
6. 62Cu-PTSM A generator-based PET radiopharmaceutical for myocardial perfusion imaging . Schwaiger M. Cardiac Positron Emission Tomography. 1996;161-172 Kluwer, Boston, MA.
7. 4-methylthiosemicarbazonato) copper(II) Synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion . J. Nucl. Med. 31:1990;1989-1996.
8. 62Cu-PTSM and PET in human subjects. J. Nucl. Med. 37:1996;1294-1300.
9. 62Cu-PTSM and positron emission tomography. Circulation. 87:1993;173-183.
10. 4-methylthiosemicarbazone) . Nucl. Med. Biol. 16:1989;791-797.
11. John E., Green M.A. Structure-activity relationships for metal-labeled blood flow tracers Comparison of ketoaldehyde bis(thiosemicarbazonato)copper(II) derivatives . J. Med. Chem. 33:1990;1764-1770.
12. Lim J.K., Mathias C.J., Green M.A. Mixed bis(thiosemicarbazone) ligands for the preparation of copper radiopharmaceuticals Synthesis and evaluation of tetradentate ligands containing two dissimilar thiosemicarbazone functions . J. Med. Chem. 40:1997;132-136.
13. Mathias C.J., Bergmann S.R., Green M.A. Development and validation of a solvent extraction technique for determination of Cu-PTSM in blood. Nucl. Med. Biol. 20:1993;343-349.
14. Mathias C.J., Bergmann S.R., Green M.A. Species-dependent binding of copper(II) bis(thiosemicarbazone) radiopharmaceuticals to serum albumin. J. Nucl. Med. 36:1995;1451-1455.
15. Mathias C.J., Welch M.J., Raichle M.E., Mintun M.A., Lich L.L., McGuire A.H., Zinn K.R., John E.K., Green M.A. Evaluation of a potential generator-produced PET tracer for cerebral perfusion imaging Single-pass cerebral extraction measurements and imaging with radiolabeled Cu-PTSM . J. Nucl. Med. 31:1990;351-359.
16. Melon P.G., Brihaye C., Degueldre C., Guillaume M., Czichosz R., Rigo P., Kulbertus H., Comar D. Myocardial kinetics of potassium-38 in humans and comparison with copper-62-PTSM. J. Nucl. Med. 35:1994;1116-1122.
17. Minkel D.T., Saryan L.A., Petering D.H. Structure-function correlations in the reaction of bis(thiosemicarbazone) copper(II) complexes with Ehrlich acites tumor cells. Cancer Res. 38:1978;124-129.
18. Okazawa H., Yonekura Y., Fujibayashi Y., Mukai T., Nishizawa S., Magata Y., Ishizu K., Tamaki N., Konishi J. Measurement of regional cerebral blood flow with copper-62-PTSM and a three-compartment model. J. Nucl. Med. 37:1996;1089-1093.
19. Okazawa H., Yonekura Y., Fujibayashi Y., Nishizawa S., Magata Y., Ishizu K., Tanaka F., Tsuchida T., Tamaki N., Konishi J. Clinical application and quantitative evaluation of generator-produced copper-62-PTSM as a brain perfusion tracer for PET. J. Nucl. Med. 35:1994;1910-1915.
20. Scovill J.P. 1,1-Disubstituted -6-[1-arylethylidene)amino]-2,5-dithiobiureas. Phosphorus, Sulfur, Silicon. 60:1991;15-19.
21. Shelton M.E., Green M.A., Mathias C.J., Welch M.J., Bergmann S.R. Assessment of regional myocardial and renal blood flow using copper-PTSM and positron emission tomography. Circulation. 82:1990;990-997.
22. Tadamura E., Tamaki N., Okazawa H., Fujibayashi Y., Kudoh T., Yonekura Y., Magata Y., Nohara R., Sasayama S., Konishi J. Generator-produced copper-62-PTSM as a myocardial PET perfusion tracer compared with nitrogen-13-ammonia. J. Nucl. Med. 37:1996;729-735.
23. 4-methylthiosemicarbazone) (Cu-PTSM), a metal complex with selective NADH-dependent reduction by complex I in brain mitochondria A potential radiopharmaceutical for mitochondria-function imaging with positron emission tomography (PET) . Biol. Pharm. Bull. 18:1995;1126-1129.
24. Wallhaus T.R., Lacy J., Whang J., Green M.A., Nickles R.J., Stone C.K. Human distribution and dosimetry of the PET perfusion agent copper-62-PTSM. J. Nucl. Med. 39:1998;1958-1964.
25. Winkelmann D.A., Bermke Y., Petering D.H. Comparative properties of the antineoplastic agent 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone) copper(II) and related chelates Linear free energy relationships . Bioinorg. Chem. 3:1974;261-277.
26. 4-methylthiosemicarbazone) for tissue blood flow measurements using a trapped tracer model. Eur. J. Nucl. Med. 21:1994;336-341.